Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide
range of bacteria. We tested its activity in comparison with four other qu
inolones and isoniazid against clinical isolates of mycobacteria. It proved
to be the most active of the quinolones tested against Mycobacterium tuber
culosis (MIC90 0.25 mg/L), Mycobacterium avium-intracellulare (MIC90 1.0 mg
/L), Mycobacterium kansasii (MIC90 0.06 mg/L) and Mycobacterium fortuitum (
MIC90 1 mg/L). These data indicate that moxifloxacin merits further study a
s an antimycobacterial agent.